Novel CD37 antibody-drug conjugate shows promise in targeting the Achilles’ heel of acute myeloid leukemia cells.

Initiate a suite of clinical trials in 2025 intended to support global registration of NX-5948 for the treatment of chronic lymphocytic ...

Bispecific antibodies (BsAbs) are a major advancement in therapeutic oncology and hematology, capable of simultaneously engaging two distinct targets. This ...

Samsung’s ADC segregated suite, equipped with a 500-liter reactor, supports the development and manufacture of ADC therapies.

Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of ...

As we enter the new year, all eyes are on the biotech companies awaiting key FDA decisions in January. In 2024, the FDA approved 50 ...

However, the oral doses of Qulipta can range from 10 mg to 60 mg per day. There are more research studies on the use of monoclonal antibody drugs rather than gepants, but studies of Qulipta with a 60 ...

· Zooming in on the understated but vital roles of CMC and open integration platforms Author: Siyuan Wang, head of strategic ...

From local drug discovery to global innovation, economic uncertainty is taking a toll on China’s innovative biotech system, forcing local companies to weather unpredictable storms, investors said ...

A recent survey reveals a significant decline in teen drug and alcohol use since 2017, reaching its lowest point in 2024. Researchers attribute this drop to pandemic lockdowns disrupting social ...

The US Food and Drug Administration (USFDA) has revoked the emergency use authorisation for four Covid-19 antibody-based drugs from pharma giants, citing expired shelf lives. In a letter dated earlier ...

The FDA said that the shelf life of the drugs had expired, and they had not been authorized for administration to patients for more than a year due to the circulation of non-susceptible variants.